YOLFTbeta
IXICO PLC

IXICO PLC

IXI · LSE · Healthcare / Biotechnology

12.75GBX-0.25 (-1.92%)

Price History

Full chart

Market Stats

Previous Close13.00
Open13.00
Day Range12.50 – 13.13
52-Week Range6.26 – 14.00
Volume152.19K
Market Cap16.42M
P/E (TTM)0.00
Forward P/E47.39
EPS-0.02
Dividend Yield0.00%
Beta0.11
50-Day Avg7.67
200-Day Avg8.43

About

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI; trial management; data analytics; post marketing surveillance and clinical diagnostics; and consultancy services. In addition, the company offers IXICO platform, an AI-enabled technology platform for neuroimaging data management and analysis. Its services are used for various therapeutic areas comprising Alzheimer's, Huntington's, Multiple Sclerosis, and Parkinson's diseases, as well as other rare neurological diseases, other Demyelinating disorders, and other Parkinsonian disorders. It has collaboration with Medidata to create neuroimaging clinical trials platform. The company is based in London, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Bram Goorden M.Sc.
  • Employees79
  • HeadquartersGriffin Court, London, United Kingdom, EC1A 9PN, UK
  • Websitehttps://ixico.com

Leadership

  • Mr. Bram Goorden M.Sc.CEO & Executive Director · b. 1973
  • Mr. Grant Robert NashCFO, COO, Company Secretary & Executive Director · b. 1976
  • Prof. Daniel RueckertCo-Founder & Member of Scientific Advisory Board
  • Prof. Derek Lionel Glendon Hill Ph.D.Co-Founder and President of Regulatory Science & External Relations · b. 1966
  • Prof. David Hawkes CPhys, FInstP, FIPEM, FREng, Ph.D.Co-Founder & Member of Scientific Advisory Board
  • Prof. Joseph HajnalCo-Founder & Member of Scientific Advisory Board
  • Mr. Mark AustinChief Technology Officer
  • Dr. Robin WolzChief Scientific Officer
  • Ms. Hannah EsfahanianHR Manager
  • Mr. James ChandlerChief Business Officer

Financials

Income Statement

Currency: GBP1993-08-311994-08-311995-08-311996-08-311997-08-311998-08-311999-08-312000-08-312001-08-312002-08-312003-08-312004-08-312005-08-312006-08-312007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-05-312013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue302.00K134.00K1.11M934.00K45.00K713.00K2.45M2.08M1.47M2.71M2.43M1.07M7.38M1.88M3.12M2.62M867.00K697.00K67.00K18.72K3.65M10.00K2.56M3.12M3.27M4.10M5.39M7.56M9.53M9.19M8.64M6.67M5.77M6.53M
Growth (%)--55.63%+731.34%-16.16%-95.18%+1484.44%+243.20%-15.08%-29.21%+84.50%-10.57%-55.83%+588.25%-74.48%+65.75%-15.96%-66.95%-19.61%-90.39%-72.06%+19379.62%-99.73%+25497.50%+21.69%+4.91%+25.46%+31.56%+40.17%+26.07%-3.59%-5.95%-22.89%-13.49%+13.32%
Cost of Revenue-------194.00K---10.00K400.00K341.00K250.00K169.00K186.00K87.00K001.30M1.30M975.00K1.32M1.68M1.79M2.22M2.62M3.62M3.66M3.87M3.40M3.06M3.63M
Gross Profit302.00K134.00K1.11M934.00K45.00K713.00K2.45M2.08M1.47M2.71M2.43M1.06M6.98M1.54M2.87M2.45M681.00K610.00K67.00K18.72K2.34M-1.29M1.58M1.79M1.59M2.31M3.17M4.94M5.91M5.53M4.77M3.27M2.71M2.91M
Gross Margin100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%99.07%94.58%81.89%91.99%93.56%78.55%87.52%100.00%100.00%64.23%-12940.00%61.91%57.53%48.59%56.44%58.82%65.36%61.98%60.21%55.18%49.06%47.02%44.48%
Operating Expense1.01M2.20M761.00K1.62M3.60M4.63M5.82M4.53M5.01M7.03M8.38M8.06M10.92M8.16M9.42M5.20M5.06M5.11M8.61M9.31M2.01M3.89M2.77M2.94M3.75M3.75M3.97M4.58M5.67M4.42M3.86M4.71M4.87M5.44M
Operating Income-706.00K-2.07M353.00K-685.00K-3.55M-3.92M-3.38M-2.45M-3.54M-4.31M-5.95M-7.00M-3.94M-6.62M-6.55M-2.74M-4.38M-4.50M-8.55M-9.30M331.00K-5.18M-1.18M-1.15M-2.16M-1.43M-797.00K364.00K236.00K1.12M908.00K-1.44M-2.15M-2.53M
Operating Margin-233.77%-1544.03%31.69%-73.34%-7893.33%-550.07%-137.92%-117.85%-240.31%-158.92%-245.32%-652.61%-53.39%-351.73%-209.90%-104.61%-505.31%-646.05%-12756.72%-49665.54%9.08%-51800.00%-46.23%-36.82%-66.22%-34.90%-14.78%4.81%2.48%12.17%10.51%-21.56%-37.36%-38.74%
EBITDA-665.00K-2.03M389.00K-410.00K-2.94M-3.42M-3.01M-2.06M-2.74M-3.71M-5.57M-6.91M-3.85M-6.51M-5.76M-2.63M-4.09M-4.15M-8.50M-9.27M612.00K-5.15M-1.05M-1.17M-1.82M-1.24M-659.00K323.00K1.29M1.73M1.55M-707.00K-1.95M-2.02M
EBITDA Margin-220.20%-1513.43%34.92%-43.90%-6535.56%-479.94%-122.84%-98.89%-186.06%-136.70%-229.54%-644.50%-52.18%-345.51%-184.47%-100.46%-472.32%-594.76%-12682.59%-49521.83%16.79%-51530.00%-40.93%-37.53%-55.60%-30.22%-12.22%4.27%13.58%18.80%17.90%-10.61%-33.73%-30.95%
Net Income-720.00K-2.20M189.00K-565.00K-3.06M-3.63M-3.22M-2.18M-2.65M-3.29M-5.30M-6.23M-3.33M-5.64M-5.81M-2.27M-3.91M-3.80M-7.66M-7.77M540.00K-4.77M-1.72M-1.19M-2.12M-1.54M-668.00K432.00K952.00K1.51M1.03M-1.18M-2.00M-1.65M
Net Income Margin-238.41%-1639.55%16.97%-60.49%-6811.11%-509.68%-131.63%-105.05%-180.35%-121.04%-218.50%-580.78%-45.08%-299.47%-186.25%-86.73%-451.10%-545.48%-11429.85%-41493.34%14.81%-47670.00%-67.15%-38.33%-64.84%-37.49%-12.38%5.71%9.99%16.45%11.94%-17.67%-34.70%-25.27%
R&D558.00K593.00K474.00K1.18M2.93M3.86M4.87M3.39M4.03M6.00M7.23M6.35M8.91M6.54M7.50M4.25M3.78M4.01M7.46M8.29M694.00K2.79M1.03M1.23M1.58M1.26M1.03M1.00M1.31M1.24M1.22M925.00K1.50M1.33M
R&D as % of Total Revenue184.77%442.54%42.55%125.91%6511.11%541.65%199.06%163.33%274.17%221.19%297.82%592.11%120.76%347.32%240.31%161.95%436.33%575.75%11135.82%44296.50%19.03%27860.00%40.11%39.61%48.44%30.63%19.15%13.27%13.73%13.49%14.08%13.88%26.01%20.32%
Interest Expense14.00K130.00K164.00K99.00K8.00K12.00K9.00K9.00K8.00K4.00K4.00K251.00K200361.00K5.00K253.00K847.00K260.00K724.00K211.48K090.00K-000025.00K18.00K22.00K33.00K29.00K25.00K16.00K
Interest Expense % of Total Revenue4.64%97.01%14.72%10.60%17.78%1.68%0.37%0.43%0.54%0.15%0.16%23.41%0.00%19.17%0.16%9.65%97.69%37.30%1080.60%1129.89%0.00%900.00%-0.00%0.00%0.00%0.00%0.33%0.19%0.24%0.38%0.44%0.43%0.24%

Balance Sheet

Currency: GBP1993-08-311994-08-311995-08-311996-08-311997-08-311998-08-311999-08-312000-08-312001-08-312002-08-312003-08-312004-08-312005-08-312006-08-312007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-05-312013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets453.00K188.00K339.00K9.94M7.24M3.73M3.20M5.71M14.17M12.24M6.91M7.55M14.07M8.22M4.15M8.49M4.88M24.61M18.60M10.59M-5.15M5.41M4.24M5.68M4.51M10.34M10.70M12.10M14.26M14.65M12.99M11.19M13.84M
Total Liabilities965.00K2.90M2.86M392.00K760.00K771.00K1.14M949.00K1.07M1.95M1.81M2.26M2.26M1.74M1.35M1.33M1.75M1.14M2.63M2.22M-1.56M1.60M1.53M1.60M1.82M3.01M2.78M2.98M2.78M2.16M1.56M1.72M2.10M
Total Equity-512.00K-2.71M-2.52M9.54M6.48M2.95M2.06M4.76M13.09M10.29M5.10M5.29M11.81M6.48M2.80M7.16M3.14M23.48M15.96M8.37M-3.59M3.81M2.71M4.08M2.69M7.33M7.92M9.12M11.48M12.49M11.43M9.46M11.74M
Cash71.00K32.00K-9.27M6.45M2.46M2.83M5.32M13.52M323.00K482.00K194.00K11.64M6.00M2.24M1.61M3.91M1.11M3.07M286.71K-4.49M3.29M1.93M3.12M2.41M7.86M7.26M7.95M6.68M5.77M4.03M1.79M3.54M
Total Debt57.00K44.00K24.00K64.00K165.00K163.00K117.00K116.00K63.00K8.00K--1.00K--------1.22M------213.00K597.00K516.00K387.00K314.00K179.00K
Net Debt-14.00K12.00K24.00K-9.20M-6.29M-2.29M-2.71M-5.20M-13.46M-315.00K-482.00K-194.00K-11.64M-6.00M-2.24M-1.61M-3.91M-1.11M-3.07M-286.71K--3.27M-3.29M-1.93M-3.12M-2.41M-7.86M-7.26M-7.73M-6.09M-5.25M-3.64M-1.47M-3.36M

Cash Flow

Currency: GBP1993-08-311994-08-311995-08-311996-08-311997-08-311998-08-311999-08-312000-08-312001-08-312002-08-312003-08-312004-08-312005-08-312006-08-312007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow-769.00K-1.97M338.00K-697.00K-2.51M-3.94M-1.82M-2.20M-2.62M-4.66M-3.59M-5.83M-3.79M-5.85M-5.46M-2.58M-3.40M-4.44M-6.42M-9.00M-4.44M-1.71M-1.32M-1.53M-644.00K355.00K-130.00K1.94M614.00K1.43M302.00K-1.73M-883.00K
Investing Cash Flow-25.00K-11.00K-21.00K-143.00K2.50M4.25M-508.00K-2.64M-8.25M3.71M3.67M-823.00K899.00K207.00K126.00K77.00K165.00K50.00K383.00K308.17K148.00K3.29M-44.00K75.00K-49.00K-71.00K-513.00K-1.14M-2.15M-2.25M-1.86M-377.00K-870.00K
Financing Cash Flow788.00K1.95M-335.00K10.11M-54.00K54.00K2.27M4.82M10.93M422.00K75.00K6.37M9.11M-1.00K1.57M1.87M5.54M1.59M8.01M5.90M8.49M239.25K2.71M2.71M5.16M5.16M48.00K-112.00K270.00K-114.00K-156.00K-134.00K3.50M
Capital Expenditure25.00K19.00K28.00K144.00K378.00K93.00K47.00K102.00K128.00K140.00K85.00K117.00K62.00K235.00K128.00K200.00K42.00K85.00K21.00K5.93K1.00K93.75K45.00K24.00K21.00K60.00K217.00K1.14M2.15M2.25M1.96M471.00K51.00K
Free Cash Flow-794.00K-1.99M310.00K-841.00K-2.89M-4.03M-1.87M-2.30M-2.74M-4.80M-3.67M-5.95M-3.86M-6.08M-5.58M-2.78M-3.44M-4.53M-6.45M-9.00M-4.44M-1.80M-1.36M-1.56M-665.00K295.00K-347.00K795.00K-1.54M-815.00K-1.66M-2.20M-934.00K
FCF to OCF103.25%100.96%91.72%120.66%115.07%102.36%102.58%104.63%104.89%103.00%102.37%102.01%101.63%104.02%102.35%107.75%101.24%101.91%100.33%100.07%100.02%105.50%103.42%101.56%103.26%83.10%266.92%41.04%-250.81%-56.99%-550.00%127.19%105.78%

Earnings

Report DateFeb 23, 2015Jun 4, 2015Feb 8, 2016Jun 7, 2016Jan 5, 2017May 22, 2017Dec 11, 2017May 23, 2018Dec 4, 2018May 20, 2019Dec 2, 2019May 20, 2020Dec 2, 2020May 25, 2021Sep 1, 2021Dec 7, 2021Mar 2, 2022May 24, 2022Aug 31, 2022Dec 7, 2022Mar 1, 2023May 23, 2023Aug 30, 2023Dec 5, 2023Jan 25, 2024Dec 20, 2024May 20, 2025
EPS Estimate0.000.000.000.000.000.000.00-0.000.000.000.00-0.020.00-0.000.000.00-0.000.000.000.000.000.000.00
EPS Actual0.000.000.00-0.05-0.04-0.03-0.03-0.01-0.010.000.000.010.010.020.000.010.000.000.000.020.000.000.000.000.00-0.01-0.01
Surprise--------------16.00%-------------
Timing-------------------Pre-market-Pre-market-After-hoursPre-market--

Key Statistics & Ratios

Market Cap16.42M
Enterprise Value15.09M
Trailing P/E0.00
Forward P/E47.39
PEG Ratio0.00
Price / Sales2.26
Price / Book1.51
EPS-0.02
Book Value0.116
Revenue (TTM)7.28M
Gross Profit (TTM)3.69M
EBITDA-2.67M
Profit Margin-24.98%
Operating Margin-31.43%
Return on Equity-15.80%
Return on Assets-13.24%
Shares Outstanding218.97M
Shares Float40.77M
Beta0.11
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 4, 20131:50